Position in LQDA
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$324,899
+$78,269 QoQ
Shares Held
4,075
-37.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#236
of 334 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Apollon Wealth Management, LLC holds $15,358,516 across 12 Drug Manufacturers - Specialty & Generic names. LQDA ranks #5 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
22,585 | $12,237,230 | |
| 2 | ZTS |
Zoetis Inc.
|
14,109 | $1,013,872 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
2,568 | $432,810 | |
| 4 | VTRS |
Viatris Inc
|
22,397 | $355,664 | |
| 5 | LQDA |
Liquidia Corp
This page
|
4,075 | $324,899 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
2,779 | $308,302 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,834 | $265,415 | |
| 8 | HLN |
Haleon plc
|
20,563 | $191,852 |
All Filings in LQDA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $324,899 | 4,075 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $246,630 | 6,535 | Shares | Sole | 2026-04-22 | |
| No filing history on record for this holder in this stock. | ||||||